Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone vs Lactulose for opioid-induced constipation
IRCT20210720051946N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naloxone and lactulose in opioid-induced constipation (OIC) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2022; status: completed.
02
Drugs
naloxonelactulose
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on IRCT20210720051946N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210720051946N4.